Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17 | 58 | 22 | 74 | 123 |
| Receivables | N/A | N/A | 1 | N/A | 103 |
| TOTAL | $18 | $59 | $23 | $74 | $227 |
| Non-Current Assets | |||||
| PPE Net | 5 | 6 | 6 | 6 | 4 |
| Intangibles | 0 | 0 | 571 | 585 | 600 |
| TOTAL | $5 | $6 | $577 | $592 | $604 |
| Total Assets | $23 | $64 | $599 | $665 | $831 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 28 | 28 | 19 | 36 | 75 |
| Accrued Expenses | 1 | 9 | 8 | 17 | 7 |
| TOTAL | $285 | $274 | $277 | $1,214 | $1,186 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $285 | $274 | $277 | $1,214 | $1,186 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 429 | 426 | 343 | 301 | 134 |
| Common Shares | 818 | 769 | 636 | 274 | 233 |
| Retained earnings | -12,774 | -12,578 | -11,454 | -9,868 | -9,387 |
| Other shareholders' equity | 2 | 0 | 2 | 2 | -9 |
| TOTAL | $-261 | $-210 | $323 | $-548 | $-355 |
| Total Liabilities And Equity | $24 | $64 | $599 | $665 | $831 |